Philadelphia Sits Among Nation’s Elite Life Sciences Hubs In New Colliers Rankings

The Philadelphia region takes fourth place in a new ranking of the country’s top life sciences hubs on the strength of its talent pipeline and recent real estate activity.

The analysis conducted by the commercial real estate services firm Colliers International focuses on a region’s ability to support and sustain industry growth using factors such as venture capital funding, National Institutes of Health grants and biomedical degree completions. The study, which examined 18 markets, also takes into account each region’s life sciences real estate market, specifically its office and lab space inventory along with the amount of space under construction and the space absorbed by companies over the past three years.

Boston holds the top score in the Colliers analysis, followed by the San Francisco Bay area and then San Diego. Philadelphia’s fourth-place finish puts it ahead of New Jersey, New York City and Seattle. Rounding out the top 10 are Raleigh/Durham in the eighth spot, followed by suburban Maryland and Chicago.

Colliers did not previously compile a national ranking of the top life sciences clusters in the country, instead publishing reports that listed individual category rankings.

Philadelphia’s highest scores are in net property absorption, where the region ranks third, and in three categories where it ranks fourth: biomedical degree graduates with 3,758 in 2022; office and lab space inventory with 23.7 million square feet; and square footage under construction at 2.5 million square feet.

The local region’s NIH grant funding of $1.4 billion and venture capital investments of $547 million rank sixth and seventh, respectively.

Read the full article here 

Previous

Next